Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00266825
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2005-12-15
Brief Title:
DHA Supplementation and Pregnancy Outcome
Sponsor:
Susan Carlson PhD
Organization:
University of Kansas Medical Center
Study Overview
Official Title:
Kansas University DHA Outcome Study KUDOS
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine if increasing DHA intake during pregnancy can increase gestation duration and enhance infant and childhood outcomes related to visual acuity stereoacuity attention and distractibility
Detailed Description:
Although numerous trials show benefits of postnatal DHA supplementation for visual acuity and others show benefits for cognitive function andor attention studies of increased DHA exposure during fetal life are needed especially in the US Women in the US consume low amounts of DHA compared to other world populations and this likely means less DHA transfer to the fetus than in many other populations Prenatal DHA exposure may be more important than postnatal exposure because animal studies show critical windows for brain DHA accumulation in relation to effects on neurotransmitters such as serotonin dopamine and GABA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HD047315 | NIH | None | httpsreporternihgovquickSearchR01HD047315 |